Suscribirse

Multimodal Machine Learning for Prediction of 30-Day Readmission Risk in Elderly Population - 26/06/24

Doi : 10.1016/j.amjmed.2024.04.002 
Ranel Loutati, BSc a, b, c, , Arie Ben-Yehuda, MD d, Shai Rosenberg, MD, PhD #, b, c, Yakir Rottenberg, MD, MPH e, #
a Department of Military Medicine and “Tzameret”, Faculty of Medicine, Hebrew University of Jerusalem; and the Medical Corps, Israel Defense Forces, Israel 
b Gaffin Center for Neuro-Oncology, Sharett Institute for Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Israel 
c The Wohl Institute for Translational Medicine, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Israel 
d Department of Internal Medicine, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Israel 
e Sharett Institute of Oncology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Israel 

Requests for reprints should be addressed to Ranel Loutati, BSc, Hebrew University of Jerusalem, Jerusalem 9103401, Israel.Hebrew University of JerusalemJerusalem9103401Israel.

Abstract

Background

Readmission within 30 days is a prevalent issue among elderly patients, linked to unfavorable health outcomes. Our objective was to develop and validate multimodal machine learning models for predicting 30-day readmission risk in elderly patients discharged from internal medicine departments.

Methods

This was a retrospective cohort study which included elderly patients aged 75 or older, who were hospitalized at the Hadassah Medical Center internal medicine departments between 2014 and 2020. Three machine learning algorithms were developed and employed to predict 30-day readmission risk. The primary measures were predictive model performance scores, specifically area under the receiver operator curve (AUROC), and average precision.

Results

This study included 19,569 admissions. Of them, 3258 (16.65%) resulted in 30-day readmission. Our 3 proposed models demonstrated high accuracy and precision on an unseen test set, with AUROC values of 0.87, 0.89, and 0.93, respectively, and average precision values of 0.76, 0.78, and 0.81. Feature importance analysis revealed that the number of admissions in the past year, history of 30-day readmission, Charlson score, and admission length were the most influential variables. Notably, the natural language processing score, representing the probability of readmission according to a textual-based model trained on social workers' assessment letters during hospitalization, ranked among the top 10 contributing factors.

Conclusions

Leveraging multimodal machine learning offers a promising strategy for identifying elderly patients who are at high risk for 30-day readmission. By identifying these patients, machine learning models may facilitate the effective execution of preventive actions to reduce avoidable readmission incidents.

El texto completo de este artículo está disponible en PDF.

Keywords : Hospital readmissions, Machine learning, Natural language processing


Esquema


 Funding: None.
 Conflict of Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
 Authorship: All authors read and approved the manuscript. RL: Writing – original draft, Visualization, Validation, Software, Methodology, Investigation, Formal analysis, Datacuration, Conceptualization. AB-Y: Writing – review &editing. SR: Writing – review & editing, Supervision, Conceptualization. YT: Writing – review &editing, Supervision, Conceptualization.
 Data Availability: All relevant data are available in the article/dedicated git repository. Due to privacy and other restrictions, the primary data cannot be made openly available. The models are accessible upon request for academic purposes only.


© 2024  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 137 - N° 7

P. 617-628 - juillet 2024 Regresar al número
Artículo precedente Artículo precedente
  • Re-Analyses of 8 Historical Trials in Cardiovascular Medicine Assessing Multimorbidity Burden and Its Association with Treatment Response
  • Andrew J. Foy, Eric W. Schaefer, Mohammed Ruzieh, Matthew Nudy, Omaima Ali, Vernon M. Chinchilli, Gerald V. Naccarelli
| Artículo siguiente Artículo siguiente
  • The Contribution of 18F FDG PET-CT for the Investigation of Fever of Unknown Origin and Inflammation of Unknown Origin
  • Shira Buchrits, Rotem McNeil, Tomer Avni, Danielle Fredman, Dmitri Guz, Anat Gafter-Gvili

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.